Bronchial carcinoma after lung transplantation: A single-center experience

Vajdic, 2009, Cancer incidence and risk factors after solid organ transplantation, Int J Cancer, 125, 1747, 10.1002/ijc.24439 Choi, 2000, Primary bronchogenic carcinoma after heart or lung transplantation: radiologic and clinical findings, J Thorac Imaging, 15, 36, 10.1097/00005382-200001000-00008 Delcambre, 1996, Primary bronchogenic carcinoma in transplant recipients, Transplant Proc, 28, 2884 Génébès, 2010, Characteristics of thoracic malignancies that occur after solid-organ transplantation, J Thorac Oncol, 5, 1789, 10.1097/JTO.0b013e3181f19226 2008 Rami-Porta, 2009, The revised TNM staging system for lung cancer, Ann Thorac Cardiovasc Surg, 15, 4 Mizushima, 1995, Clinical characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary fibrosis, Chest, 108, 1272, 10.1378/chest.108.5.1272 Spiekerkoetter, 1998, Prevalence of malignancies after lung transplantation, Transplant Proc, 30, 1523, 10.1016/S0041-1345(98)00343-1 Collins, 2002, Bronchogenic carcinoma after lung transplantation: frequency, clinical characteristics, and imaging findings, Radiology, 224, 131, 10.1148/radiol.2241011189 Arcasoy, 2001, Bronchogenic carcinoma complicating lung transplantation, J Heart Lung Transplant, 20, 1044, 10.1016/S1053-2498(01)00301-1 McAdams, 2001, Complications (excluding hyperinflation) involving the native lung after single-lung transplantation: incidence, radiologic features, and clinical importance, Radiology, 218, 233, 10.1148/radiology.218.1.r01ja45233 Schulman, 2000, Pulmonary nodules and masses after lung and heart-lung transplantation, J Thorac Imaging, 15, 173, 10.1097/00005382-200007000-00004 Hojo, 1999, Cyclosporine induces cancer progression by a cell autonomous mechanism, Nature, 397, 530, 10.1038/17401 2011, Reduced lung-cancer mortality with low-dose computed tomographic screening, N Engl J Med, 365, 395, 10.1056/NEJMoa1102873 Dancey, 2010, mToR signaling and drug development in cancer, Nat Rev Clin Oncol, 7, 209, 10.1038/nrclinonc.2010.21 Monaco, 2009, The role of mTOR inhibitors in the management of posttransplant malignancy, Transplantation, 87, 157, 10.1097/TP.0b013e318193886e